Whole Exome Sequencing Market Report 2026

Whole Exome Sequencing Market Overview

• Whole Exome Sequencing market size has reached to $3.36 billion in 2025 • Expected to grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 21.5% • Growth Driver: Rising HIV (Human Immunodeficiency Virus) Prevalence Fuels Expansion Of The Whole Exome Sequencing Market • Market Trend: Advancements In Next-Generation Sequencing Accelerating Whole Exome Sequencing For Enhanced Diagnostics And Personalized Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Whole Exome Sequencing Market?

Whole exome sequencing refers to a genomic sequencing technique in which all of the protein-coding regions in a genome are sequenced. It is used in the laboratory to identify the mutations that may be responsible for a specific disease. The main products of whole exome sequencing are systems, kits, and services. The system refers to the examination of how biological elements such as molecules, cells, and organs interact and behave. The various technologies used are sequencing by synthesis, ion semiconductor sequencing, and others that are used for diagnostics, drug discovery and development, personalized medicine, agriculture, and animal research applications by hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and others.

What Is The Whole Exome Sequencing Market Growth Forecast?

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 21.5%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of genomic medicine programs, growing integration of sequencing data into clinical decision-making, rising investments in sequencing infrastructure, increasing adoption in drug discovery. Major trends in the forecast period include increasing adoption of exome-based diagnostic testing, rising use of sequencing in rare disease detection, growing integration of bioinformatics analysis platforms, expansion of personalized medicine applications, enhanced focus on cost-effective sequencing workflows.

Global Whole Exome Sequencing Market Segmentation

1) By Product: Systems, Kits, Services 2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies 3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research 4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users Subsegments: 1) By Systems: Sequencing Systems, Data Analysis Systems 2) By Kits: Library Preparation Kits, Exome Enrichment Kits, Sequencing Kits 3) By Services: Data Analysis Services, Consulting Services, Custom Sequencing Services

What Is The Driver Of The Whole Exome Sequencing Market?

Increasing HIV (human immunodeficiency virus) prevalence is expected to propel the growth of the whole exome sequencing market going forward. HIV refers to a virus that targets the immune system of the body. Whole exome sequencing is used to provide genomic structures of viruses that are useful for personalized treatment and vaccine designs for HIV. For instance, in August 2024, according to the Minority HIV/AIDS Fund (MHAF), an US-based government agency, an estimated in 2023, approximately 39.9 million individuals worldwide were living with HIV, consisting of 38.6 million adults and 1.4 million children, compared to previous years. Therefore, the increasing HIV prevalence is driving the growth of the whole exome sequencing industry.

Key Players In The Global Whole Exome Sequencing Market

Major companies operating in the whole exome sequencing market are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.

Global Whole Exome Sequencing Market Trends and Insights

Major companies operating in the whole exome sequencing market are developing advanced next-generation sequencing (NGS) ultra-fast technology to enhance the speed and accuracy of genetic analysis, enabling quicker diagnostics and personalized treatment plans in healthcare. Next-generation sequencing (NGS) ultra-fast technology enhances whole exome sequencing by quickly analyzing exonic areas, allowing for the rapid detection of genetic mutations crucial for diagnosis and research. For instance, in January 2023, Qiagen, a Germany-based medical devices and health care company, launched the CLC genomics workbench premium with lightspeed technology, enabling efficient analysis of whole genome sequencing (WGS) and whole exome sequencing (WES) data. This innovation processes an entire genome in just 25 minutes for about $1 using cloud computing, while also supporting local hardware. By reducing time and costs, lightSpeed enhances the accessibility of large-scale genetic testing in the WES market.

What Are Latest Mergers And Acquisitions In The Whole Exome Sequencing Market?

In February 2023, NIMGenetics Genómica y Medicina S.L., a Spain-based biotechnology company focused on human genetic diagnostics, acquired Gene Predictis, S.A. for an undisclosed amount. With this acquisition, NIMGenetics aims to accelerate its expansion in Central European markets and strengthen its position in the European genetic diagnostics space by combining both companies’ genomic service portfolios and customer bases. Gene Predictis S.A. is a Switzerland-based diagnostic company specializing in preventive health and precision medicine, offering proprietary algorithms and diagnostic tools in areas such as genetics, pharmacogenomics, microbiology, and epidemiology.

Regional Outlook

North America was the largest region in the whole exome sequencing market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Whole Exome Sequencing Market?

The whole exome sequencing market consists of revenues earned by entities by providing services such as exome capture, library construction, deep sequencing, raw data quality control, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole exome sequencing market also includes sales of instruments, comparison tools, and sequencing reagents which are used in providing whole exome sequencing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Whole Exome Sequencing Market Report 2026?

The whole exome sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the whole exome sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.